Diazepam 10 MG/2 ML carpuject 2ML
Ended Awarded
- Contract number
- SPE2DB26FSV00
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,669
Award facts
- Contract value 100% obligated
- $1,669.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,669.14 to DMS Pharmaceutical Group Inc. for the supply of Diazepam 10 mg/2 mL Carpuject 2mL injectable medication. The award, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, was made without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense medical requirements.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract designated SPE2DR, awarded under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as one of multiple regional prime vendor contractors within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support recurring medical supply needs of military healthcare facilities worldwide, with the company's established performance on numerous delivery orders demonstrating its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FSV00?
SPE2DB26FSV00 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FSV00 worth?
The government has obligated $1,669 on SPE2DB26FSV00.
Is contract SPE2DB26FSV00 an order under another contract?
Yes. SPE2DB26FSV00 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB26FSV00 competed?
The extent of competition for SPE2DB26FSV00 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award